TH120271B - Dihydroquinolone derivatives - Google Patents
Dihydroquinolone derivativesInfo
- Publication number
- TH120271B TH120271B TH1101001281A TH1101001281A TH120271B TH 120271 B TH120271 B TH 120271B TH 1101001281 A TH1101001281 A TH 1101001281A TH 1101001281 A TH1101001281 A TH 1101001281A TH 120271 B TH120271 B TH 120271B
- Authority
- TH
- Thailand
- Prior art keywords
- formula
- chemical formula
- disorders
- sleep
- dihydroquinolone
- Prior art date
Links
- TZOYXRMEFDYWDQ-UHFFFAOYSA-N 3,4-dihydro-1H-quinolin-2-one Chemical class C1=CC=C2NC(=O)CCC2=C1 TZOYXRMEFDYWDQ-UHFFFAOYSA-N 0.000 title claims 2
- 239000000126 substance Substances 0.000 claims abstract 8
- 150000003839 salts Chemical class 0.000 claims abstract 2
- 239000011780 sodium chloride Substances 0.000 claims abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 claims 2
- 125000004429 atoms Chemical group 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 206010001897 Alzheimer's disease Diseases 0.000 abstract 1
- 206010003736 Attention deficit/hyperactivity disease Diseases 0.000 abstract 1
- 208000008581 Brain Disease Diseases 0.000 abstract 1
- 206010009191 Circadian rhythm sleep disease Diseases 0.000 abstract 1
- 206010012601 Diabetes mellitus Diseases 0.000 abstract 1
- 206010062060 Hyperlipidaemia Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000001797 Obstructive Sleep Apnea Diseases 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 206010040979 Sleep apnoea syndrome Diseases 0.000 abstract 1
- 206010040984 Sleep disease Diseases 0.000 abstract 1
- 206010041349 Somnolence Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 201000006287 attention deficit hyperactivity disease Diseases 0.000 abstract 1
- 235000014632 disordered eating Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drugs Drugs 0.000 abstract 1
- 201000006180 eating disease Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Abstract
การประดิษฐ์นี้ให้ยาป้องกันโรคหรือยารักษาโรคภาวะสมองเสี่อม, โรคอัลไซเมอร์, โรค สมาธิสั้น, โรคจิตเภท, อาการผิดปรกติเกี่ยวกับการรับประทานอาหาร, โรคอ้วน, เบาหวาน, ภาวะ เลือดมีสารไขมันมาก, ความผิดปรกติในการนอนหลับ, ภาวะง่วงเกิน, กลุ่มอาการหยุดหายใจขณะ หลับ, อาการผิดปรกติเกี่ยวกับวงจรการหลับ-ตื่น, ภาวะซึมเศร้า, เมื่อจมูกอักเสบเหตุภูมิแพ้ หรือ โรคอื่นๆ สารอนุพันธ์ไดไฮโดรควิโนลิโนน ซึ่งแสดงไว้โดยสูตร (1) หรือเกลือที่ยอมรับได้ทาง เภสัชกรรมของสารเหล่านั้น [สูตร1] (สูตรเคมี) {ซึ่ง Q แทน สูตร (A) หรือ (B) ต่อไปนี้} [สูตร 2 ] (สูตรเคมี) (สูตรเคมี) (A) (B): The invention provides prophylactic or drug treatment for brain disorder, Alzheimer's disease, ADHD, schizophrenia, eating disorders, obesity, diabetes, hyperlipidemia. , Sleep disorders, excessive drowsiness, obstructive sleep apnea syndrome, sleep-wake cycle disorders, depression, allergic rhinitis or other ailments. Winolinone Which is denoted by formula (1) or salt acceptable via Pharmacy of those substances [Formula 1] (Chemical Formula) {where Q represents the following formula (A) or (B)} [Formula 2] (Chemical formula) (Chemical formula) (A) (B):
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH120271A TH120271A (en) | 2013-01-28 |
| TH120271B true TH120271B (en) | 2013-01-28 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011008336A (en) | Dihydroquinolinone derivatives. | |
| HK1145834A1 (en) | Phenylpyrazole derivatives | |
| MX349470B (en) | Heterocyclic compound and use thereof. | |
| MA32898B1 (en) | POSITIVE ALLOSTERIC MODULATORS OF ARYLMETHYLBENZOQUINAZOLINONE M1 RECEPTOR | |
| MX2011011489A (en) | Isoxazole-pyridine derivatives. | |
| MX2011007774A (en) | Isoxazole-isoxazole and isoxazole-isothiazole derivatives. | |
| EA201391029A1 (en) | OXAZIN DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF NEUROLOGICAL DISORDERS | |
| JP2014526435A5 (en) | ||
| MX2011011273A (en) | Isoxazole-pyrazole derivatives. | |
| EA201171172A1 (en) | APPLICATION IN THERAPY DERIVATIVES OF HINAZOLINDION | |
| MX2013008056A (en) | 1,4-oxazepines as bace1 and/or bace2 inhibitors. | |
| BR112012003464B8 (en) | pyranyl aryl methyl benzoquinoquinone compounds, their use, and pharmaceutical composition | |
| PH12014501293A1 (en) | Phenylpyrrole derivative | |
| MX2016013412A (en) | Morpholin-pyridine derivatives. | |
| BR112013010558A2 (en) | dihydro-oxazol-2-amine derivatives | |
| TH120271B (en) | Dihydroquinolone derivatives | |
| TH120271A (en) | Dihydroquinolone derivatives | |
| WO2009064836A3 (en) | Kynurenine-aminotransferase inhibitors | |
| NZ703628A (en) | Diazepinone derivatives useful for the treatment of fragile x syndrome, parkinsons or reflux disease | |
| EA201391314A1 (en) | NEW PHENILPYRIDINE DERIVATIVE AND CONTAINING HER MEDICINE | |
| DE602007012683D1 (en) | Substituted tetrahydroquinolinesulfonamide compounds, their preparation and their use as medicaments | |
| EP2463293A4 (en) | Azacyclohexapeptide or its pharmaceutical acceptable salt, preparing method and use thereof | |
| IL202282A0 (en) | Prolinamide-tetrazole derivatives as nk3 receptor antagonists | |
| TN2013000034A1 (en) | Heterocyclic compound and use thereof | |
| PL400584A1 (en) | Medical use of 3-(thiophen-2-yl)-1,2,4-triazole-5-thione |